Wockhardt Limited (WOCKPHARMA.BO)
INR 1264.45
(4.26%)
INR 1264.45
(4.26%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 6.4 Billion INR | -2.74% |
| 2022 | 6.58 Billion INR | -14.43% |
| 2021 | 7.69 Billion INR | -3.75% |
| 2020 | 7.99 Billion INR | 14.95% |
| 2019 | 6.95 Billion INR | -15.17% |
| 2018 | 8.19 Billion INR | -4.25% |
| 2017 | 8.55 Billion INR | -22.77% |
| 2016 | 11.07 Billion INR | 0.53% |
| 2015 | 11.02 Billion INR | 7.97% |
| 2014 | 10.2 Billion INR | 2.81% |
| 2013 | 9.92 Billion INR | -6.23% |
| 2012 | 10.58 Billion INR | 19.16% |
| 2011 | 8.88 Billion INR | 24.5% |
| 2010 | 7.13 Billion INR | -6.76% |
| 2009 | 7.65 Billion INR | -7.75% |
| 2008 | 8.29 Billion INR | 7.94% |
| 2007 | 7.68 Billion INR | 78.78% |
| 2006 | 4.29 Billion INR | 56.56% |
| 2005 | 2.74 Billion INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 FY | 6.4 Billion INR | -2.74% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 6.35 Billion INR | 0.0% |
| 2023 Q4 | 6.4 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q4 | 6.58 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 6.58 Billion INR | -14.43% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 7.48 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 7.65 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 7.69 Billion INR | -3.75% |
| 2021 Q4 | 7.69 Billion INR | 0.0% |
| 2020 Q4 | 7.99 Billion INR | 0.0% |
| 2020 FY | 7.99 Billion INR | 14.95% |
| 2020 Q2 | 8.47 Billion INR | 0.0% |
| 2019 Q2 | 7.3 Billion INR | 0.0% |
| 2019 Q4 | 6.95 Billion INR | 0.0% |
| 2019 FY | 6.95 Billion INR | -15.17% |
| 2018 Q2 | 9.28 Billion INR | 0.0% |
| 2018 Q4 | 8.19 Billion INR | 0.0% |
| 2018 FY | 8.19 Billion INR | -4.25% |
| 2017 Q4 | 8.55 Billion INR | 0.0% |
| 2017 Q2 | 9.37 Billion INR | 0.0% |
| 2017 FY | 8.55 Billion INR | -22.77% |
| 2016 Q2 | 11.31 Billion INR | 0.0% |
| 2016 FY | 11.07 Billion INR | 0.53% |
| 2016 Q4 | 11.07 Billion INR | 0.0% |
| 2015 Q2 | 10.85 Billion INR | 0.0% |
| 2015 Q4 | 11.02 Billion INR | 0.0% |
| 2015 FY | 11.02 Billion INR | 7.97% |
| 2014 FY | 10.2 Billion INR | 2.81% |
| 2014 Q2 | 10.94 Billion INR | 0.0% |
| 2014 Q4 | 10.2 Billion INR | 0.0% |
| 2013 FY | 9.92 Billion INR | -6.23% |
| 2013 Q4 | 9.92 Billion INR | 0.0% |
| 2013 Q2 | 11.12 Billion INR | 0.0% |
| 2012 Q4 | 10.58 Billion INR | 0.0% |
| 2012 FY | 10.58 Billion INR | 19.16% |
| 2011 Q4 | 8.88 Billion INR | 0.0% |
| 2011 FY | 8.88 Billion INR | 24.5% |
| 2010 FY | 7.13 Billion INR | -6.76% |
| 2009 FY | 7.65 Billion INR | -7.75% |
| 2008 FY | 8.29 Billion INR | 7.94% |
| 2007 FY | 7.68 Billion INR | 78.78% |
| 2006 FY | 4.29 Billion INR | 56.56% |
| 2005 FY | 2.74 Billion INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 61.06% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 93.475% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 3.989% |
| Granules India Limited | 13 Billion INR | 50.79% |
| Indoco Remedies Limited | 3.53 Billion INR | -81.272% |
| Achyut Healthcare Limited | 568 Thousand INR | -1126660.563% |
| Ajanta Pharma Limited | 8.28 Billion INR | 22.739% |
| Alkem Laboratories Limited | 26.61 Billion INR | 75.951% |
| Alpa Laboratories Limited | 136.65 Million INR | -4583.395% |
| Brooks Laboratories Limited | 96.1 Million INR | -6559.175% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -180.847% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -344.327% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -440.325% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 89.93% |
| Eris Lifesciences Limited | 1.89 Billion INR | -238.567% |
| FDC Limited | 3.88 Billion INR | -64.572% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 74.533% |
| Gufic Biosciences Limited | 2 Billion INR | -219.23% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -6019.893% |
| Ipca Laboratories Limited | 24.71 Billion INR | 74.103% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -4167.52% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -6433.012% |
| Lasa Supergenerics Limited | 190.43 Million INR | -3260.744% |
| Laurus Labs Limited | 18.45 Billion INR | 65.319% |
| Lupin Limited | 49.53 Billion INR | 87.081% |
| Mankind Pharma Limited | 15.53 Billion INR | 58.802% |
| Medicamen Biotech Limited | 593.75 Million INR | -977.891% |
| Medico Remedies Limited | 163.37 Million INR | -3817.44% |
| Megasoft Limited | - INR | -Infinity% |
| NATCO Pharma Limited | 7 Billion INR | 8.637% |
| Piramal Pharma Limited | 21.75 Billion INR | 70.587% |
| RPG Life Sciences Limited | 1.01 Billion INR | -533.663% |
| Sigachi Industries Limited | 707.2 Million INR | -804.968% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 93.515% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -176.822% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -2935.837% |
| Unichem Laboratories Limited | 7.04 Billion INR | 9.178% |
| Wanbury Limited | 360.23 Million INR | -1676.633% |
| Windlas Biotech Limited | 621.89 Million INR | -929.121% |
| ZIM Laboratories Limited | 812.62 Million INR | -687.567% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 81.406% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Divi's Laboratories Limited | 31.84 Billion INR | 79.899% |
| Hester Biosciences Limited | 755.81 Million INR | -746.774% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -486.564% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -2114.173% |
| Bal Pharma Limited | 878.11 Million INR | -628.835% |
| Strides Pharma Science Limited | 11.26 Billion INR | 43.174% |
| Venus Remedies Limited | 1.21 Billion INR | -425.927% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 0.445% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 9.751% |
| Shilpa Medicare Limited | 3.44 Billion INR | -85.546% |
| Aarti Drugs Limited | 4.85 Billion INR | -31.717% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -50.645% |
| Suven Life Sciences Limited | 7.08 Million INR | -90231.687% |
| Ind-Swift Limited | 640.91 Million INR | -898.572% |
| Valiant Laboratories Limited | 100.15 Million INR | -6290.159% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -27.361% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -77.926% |
| Themis Medicare Limited | 705.74 Million INR | -806.846% |
| Hikal Limited | 3.03 Billion INR | -110.72% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 71.918% |
| Sequent Scientific Limited | 3.46 Billion INR | -84.847% |
| Novartis India Limited | 448.6 Million INR | -1326.661% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 50.372% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -25000.992% |
| Neuland Laboratories Limited | 3.5 Billion INR | -82.637% |
| Morepen Laboratories Limited | 2.48 Billion INR | -157.448% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -15948.144% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -417.633% |